Read + Share
Amedeo Smart
Independent Medical Education
Ottum S, Sethi N, Bellone S, Demirkiran C, et al. Preclinical activity of tisotumab vedotin, an antibody-drug conjugate targeting tissue factor, in uterine serous carcinoma. Gynecol Oncol 2026;211:191-199.PMID: 42456482
Email
LinkedIn
Privacy Policy